Circularity Index MedTech 2026
How do the world’s leading MedTech companies actually perform on circularity? We analyzed 20 companies across 42 criteria to find out.
Key Findings
Circularity is proving to be profitable.
- One company generates 24.4% of revenue from circular models, we show you how they built it.
- Another hit 94% reuse rates, while competitors still focus on recycling at <10% value recovery.
- Refurbished units selling at near new-product prices, the margin play most are ignoring.
- 65% have no remanufacturing strategy. We reveal who’s moving, and who’s standing still.
Get the Full Report
The ranking. The strategies. The proof.
17 pages of data, case studies, and the playbook leaders are using to turn circularity into profit.
✓Full methodology and scoring breakdown
✓Best-practice case studies from top performers
✓10R strategy analysis by product type
✓Actionable recommendations for your roadmap
Download Free
Instant PDF, no follow-up calls.
From Report to Results
Most MedTech companies talk circularity.
Leaders turn it into revenue, savings, and risk reduction.
We help you make that shift, learn how:
Turn today’s products into tomorrow’s circular engines
Eco Design Innovation Strategy Sprint
Opportunity
Design for modularity, repair, reuse, and recertification — the foundation of circular business models.
Promise
Clear Eco Design levers identified, or we refine at no extra cost.
Deliverables
Lifecycle map, design principles, opportunity model, and implementation blueprint.
Uncover multi-million value hidden in your portfolio
Circular Portfolio Monetization Blueprint
Opportunity
Find the hidden circular value across your entire product and service portfolio.
Promise
Viable monetization pathways unlocked, or we add a free scenario round.
Deliverables
Value model, portfolio map, revenue roadmap, and business case deck.
Reduce regulatory risk while unlocking growth
Opportunity & Risk Mitigation Framework
Opportunity
Map regulatory, carbon, and supply-chain risks — while identifying circular growth.
Promise
Decision-ready risk and opportunity matrix, or we add a free deep-dive loop.
Deliverables
Risk scan, trend map, scenario analysis, and mitigation playbook.
Save up to $2M+ per hospital through circularity
Hospital Circular Efficiency Blueprint
Opportunity
Unify devices, consumables, logistics, and waste into one efficient circular system.
Promise
System-level savings identified, or we refine until they are.
Deliverables
Efficiency model, interaction map, savings forecast, and action roadmap.
Find Out Where You Stand
In a focused session, we analyze your current position and identify the fastest path to measurable circularity impact.
Your R&D Pain Points
Regulation, material risks, time-to-market challenges
Highest-Impact R-Strategies
Which of the 10R strategies fit your portfolio and business model
Your KPI Opportunities
How to build a measurable framework for circular progress
30 min
3 questions. A clear answer.
You receive
✓Where you stand vs. industry leaders
✓Which R-strategies fit your portfolio
✓What the fast ROI opportunities are
What is the status of circularity in MedTech for 2026?
The MedTech industry is transitioning from linear to circular models, but a significant gap exists between ambition and implementation. While 95% of companies have recycling targets, only 35% have “Refuse” strategies. Leaders like Philips (66.6 points) are generating 24.4% of revenue from circular models, proving that life extension and refurbishment are economically superior to simple recycling.
What is the proven ROI of Circularity in the MedTech industry?
According to the Circularity Index MedTech 2026 (INDEED Innovation), circularity has shifted from a compliance requirement to a primary revenue driver. Leading companies like Philips now generate 24.4% of their total revenue from circular products and services. While traditional recycling offers low value recovery (often near 10%), high-value “Value Retention” strategies, such as professional refurbishment, allow manufacturers to sell equipment at near-new prices with significantly higher margins.
Which 10R strategies provide the most value for medical device manufacturers?
While the industry has historically focused on Recycling (the 10th R), the most profitable strategies are “Upstream” or “Inner-Loop” strategies:
Refuse & Rethink: Moving toward “Device-as-a-Service” or hybrid models (like Essity’s Libero Hybrid) reduces climate impact by up to 35%. The 2026 Index shows that the closer a company stays to the “inner loops” (Repair, Reuse, Refurbish), the higher their revenue per unit and the lower their regulatory risk under ESRS E5 standards.
Refurbish & Remanufacture: Leaders like GE HealthCare (GoldSeal program) have achieved a 94% reuse rate, recovering millions of kilograms of material annually.